NCT07493694

Brief Summary

This observational retrospective and prospective registry aims to explore the relationships between clinical manifestations and radiological findings in cerebrovascular diseases. These conditions are characterized by heterogeneous radiological presentations and different etiologies, posing challenges for accurate diagnosis and effective treatment. Understanding these correlations is essential for advancing diagnostic accuracy and therapeutic strategies.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,143

participants targeted

Target at P75+ for all trials

Timeline
240mo left

Started Apr 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Apr 2046

First Submitted

Initial submission to the registry

March 5, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 25, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
20 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2046

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2046

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

20 years

First QC Date

March 5, 2026

Last Update Submit

March 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with each key MRI/CT finding in cerebrovascular disease (lesion location, vessel involvement, hemorrhagic transformation)

    Primary Outcome Measure: Diagnostic imaging trends in cerebrovascular disease Description: Key imaging findings from first MRI/CT (e.g., lesion location, vessel involvement; %).

    Baseline (at diagnosis), up to 20 years

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The registry will focus on adults aged 18 to 100 of both genders diagnosed with various cerebrovascular diseases based on clinical and imaging evaluations. Participants will be selected from a retrospective registry of patients who have undergone MRI or CT scans for clinical indications. In addition to the retrospective cohort, the registry will also include a prospective component, enrolling newly diagnosed patients who meet the same eligibility criteria.

You may qualify if:

  • Age Range: 18-100 years old.
  • Must have undergone a CT or MRI scan of the central nervous system (CNS) (for clinical reasons).

You may not qualify if:

  • Alternative diagnosis to vascular pathology that explains clinical symptoms.
  • MRI or CT non-diagnostic or non-evaluable MRI due to motion artifacts.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
20 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 5, 2026

First Posted

March 25, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2046

Study Completion (Estimated)

April 1, 2046

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share